Publications by authors named "Mario V Beccari"

Claim this Profile
O
Omadacycline for a Carbapenem-Resistant -Associated Wound Infection.
Dylan C VanDuyn, Saloni Chadha, Lauren A Paul, Andrea R Dressler, Mario V Beccari

Hosp Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
Mario V Beccari, Robert W Seabury, Bryan T Mogle, Wesley D Kufel, Christopher D Miller

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection.
Mario V Beccari, Bryan T Mogle, Eric F Sidman, Keri A Mastro, Elizabeth Asiago-Reddy

Antimicrob Agents Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections.
Bryan T Mogle, Mario V Beccari, Jeffrey M Steele, Tasaduq Fazili, Wesley D Kufel

Expert Opin Pharmacother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium.
Wesley D Kufel, Robert W Seabury, Bryan T Mogle, Mario V Beccari, Luke A Probst

Am J Health Syst Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia.
Calvin J Meaney, Mario V Beccari, Yang Yang, Jiwei Zhao

Pharmacotherapy· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.
Mario V Beccari, Calvin J Meaney

Core Evid· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis